Recall Woes Deepen For Johnson & Johnson

December 2, 2010

Recall Woes Deepen For Johnson & Johnson

MSNBC news reports that things worsened on Wednesday for the pharmaceutical giant, Johnson & Johnson, after they recalled 12 million bottles of their over-the-counter medicine, Mylanta, and nearly 85,000 bottles of AlternaGel liquid antacid.

The news source explains the company initiated the recalls because “the presence of small amounts of alcohol from flavoring agents was not noted on product packaging.”

The company explained on its Mylanta website that it is unlikely the unnoted traces of alcohol, which are in concentrations of less than 1 percent, will cause any “adverse events,” the news source reports. Nevertheless, retailers are obligated to remove the products from their shelves.

MSNBC reports that both Mylanta and AlternaGel liquid antacid are “manufactured as part of a 50/50 joint venture with Merck & Co, formed to develop and make nonprescription drugs primarily derived from Merck’s prescription drugs.” The news source goes on to explain that “J&J said the products were made at the joint venture’s plant in Lancaster, Pennsylvania.”

This latest recall only deepens the manufacturers sorrows after the company’s plant in Fort Washington, Pennsylvania, was “shut down to fix hygiene problems and other quality control lapses that in the past year have forced huge recalls of J&J’s own iconic consumer brands,” the story from MSNBC reports. Only a week ago, the report continues, “J&J recalled 9 million bottles of Tylenol because packaging did not adequately inform customers about the presence of trace amounts of alcohol.”

In the past year, “more than 200 million bottles of J&J products have been recalled,” the site reports. Those products include “painkillers Tylenol and Motrin, allergy treatment Benadryl and Rolaid antacid,” according to the news source.

The site reports this is just the latest crisis to harm “J&J’s once-pristine image and is beginning to take a significant toll on its financial results.” MSNBC points out that “U.S. sales of J&J’s consumer products plunged 25 percent in the third quarter as scores of formulations became unavailable and customers opted instead for generic store brands.”

The site also indicates that “Quality-control problems have also hounded J&J’s factory in Las Piedras, Puerto Rico, forcing recalls of Benadryl and Tylenol in June.” MSNBC reports one analyst “cautioned the U.S. Food and Drug Administration could temporarily shut down or seize the Puerto Rico plant, after having recently inspected it and noting unresolved quality-control lapses in an agency report filed Nov. 2.”

The news source explains that the negative report filed in November follows “a similar one issued by the FDA after an inspection of the plant in January and February.” MSNBC reports that last week J&J “declined to comment whether it may be forced to take special charges to account for the mounting number of recalls,” although that might change after this latest setback.

If you or a loved one has experienced serious side effects or health complications with a Johnson & Johnson product, contact Newsome Law Firm  and fill out a case evaluation form today. Our team of attorneys has experience specific to complications associated with hazardous medication. Not only can they give you the legal guidance you need, they can help you get the compensation you deserve.

Pierson, Ransdell. (December 2, 2010) “J&J heartburn worsens with Mylanta recall.” Retrieved on December 2, 2010 from MSNBC.


OVER $500,000,000 recovered
Newsome Melton has recovered over half a billion dollars for their clients.
Product Liability Lawyer - Newsome Melton

    Please do not navigate away from this page until you receive a success notification.

    Product Liability Lawyer - Newsome Melton